Jupiter Life Line Hospitals Ltd

The transcript does not mention any current or future plans for fundraising through debt or equity. Key points related to capex and funding are: - The company is investing in new hospital projects (Dombivli, Pune Bibvewadi, Mira Road) with significant capex already incurred or planned. - Capex for Dombivli is approximately INR 425 crores; Pune has about INR 45 crores spent so far; Mira Road project is in regulatory approval stage. - No direct comments or discussions about raising additional debt or equity funding were made during the call. - The company is focusing on long-term growth through greenfield projects and does not provide specific details on funding sources within this transcript. Thus, there is no explicit mention of any planned equity or debt fundraising at this time.

- Pune Bibvewadi project: Construction has started, currently at basement work stage; excavation completed. Expected to begin operations in calendar year 2028. Capex incurred so far is around INR 45 crores. - Dombivli hospital: Completed construction of 500-bed hospital at INR 425 crores capex. Launch planned for February 15, 2026, with phased bed activation starting from 200 beds. EBITDA drag expected for ~2 years before profitability. - Mira Road project: Regulatory approvals in progress; construction not yet started; no capex incurred yet. - Overall capex in 9 months FY '26: INR 425 crores for Dombivli, INR 45 crores for Pune, Mira Road yet to start. - European trade deal and medical equipment imports: Potential future capex savings due to expected reduced import duties, though impact may be dependent on implementation and sourcing from China. The company is committed to growth via greenfield expansions primarily in Western India.

- Mature hospitals' ARPOB (Average Revenue Per Occupied Bed) expected to grow in line with inflation; newer hospitals may see faster growth initially. - New hospitals like Dombivli expected to take 2-3 years for stabilization; breakeven anticipated by end of year 2 with EBITDA drag initially. - Occupancy growth limited in mature hospitals (e.g., Thane), moderate in Pune, and strong growth opportunity in Indore. - Industry-wide demand-supply mismatch with insufficient high-quality tertiary care supply; growth story expected to continue for multiple decades. - Jupiter plans to expand beyond existing 6 hospitals, committed to Western India, and intends to grow alongside supply. - Insurance renewals are inflation-linked but negotiated annually; uncertain long-term margin impact due to potential wage and cost increases. - Total income grew 9.8% YoY in Q3 FY26, mainly driven by ARPOB growth (~10% this quarter). - Focus remains on broad-spectrum full-service hospitals rather than targeting specific ARPOB levels.

- New 500-bed Dombivli hospital to start operations in Q1 FY'27, expected EBITDA drag for 1-2 years before turning profitable. - Indore hospital in growth phase expected to contribute incremental margins over next 2 years. - Mature hospitals (Thane, Pune) expected to have stable margins with limited occupancy growth; capped by finite capacity. - ARPOB (Average Revenue Per Occupied Bed) growth expected to be inflation-linked for mature hospitals; faster growth in early years for new hospitals. - Long-term ARPOB growth uncertain due to inflation, wage trends, trade, taxation; no specific margin guidance provided. - Company plans to add more hospitals (7th hospital under consideration) and grow in line with supply growth over next decade. - Expect steady revenue growth driven by capacity additions and strong demand-supply dynamics in existing markets. - PAT impacted short term due to new labor code provisions and higher depreciation from recent capex but expected to improve with ramp-up. Overall, growth outlook is positive but with initial profit pressure from new projects and long-term margin dynamics dependent on macro factors.

The transcript does not explicitly mention current or expected order book or pending orders for Jupiter Life Line Hospitals Limited. However, relevant information about ongoing and upcoming projects from the call includes: - Dombivli Hospital: Completed construction, 500 beds, INR 425 crores capex, to start operating with 200 beds from Q1 FY27, phased ramp-up planned. - Pune Bibvewadi Project: Construction started (basement work), excavation completed, capex incurred ~INR 45 crores so far, expected commissioning around calendar year 2028. - Mira Road Project: Regulatory approval in process, no construction started yet. - Overall capex for 9 months FY26 includes INR 425 crores for Dombivli and INR 45 crores for Pune. - Future potential projects or expansions include adding a seventh hospital, but no confirmed orders/orders book mentioned. No quantified current or expected order book values were disclosed in the transcript.